Medication Assisted Treatment (MAT)

What is MAT?

Medication Assisted Treatment (MAT) is the use of medications in combination with counseling and behavioral therapies for the treatment of substance use disorders. Medications approved to treat substance use disorders can help reestablish normal brain function, reduce substance cravings, and prevent relapse.

KCPH, in partnership with the Professional Services Group (PSG), provides MAT services to clients enrolled in PSG’s Comprehensive Alcohol and Drug Treatment Program (CADTP). Key components of CADTP include alcohol and other drug counseling, support groups, psychotherapy, and recovery and peer specialist support.

What medication options are available?

There are several medication options that are FDA approved to treat both alcohol use disorder and opioid use disorder. Our healthcare team will talk to you about how each medication works and help choose the best option for you.

For opioid use disorder, there are 3 FDA-approved medication options: naltrexone (i.e Vivitrol), buprenorphine (i. e Suboxone, Sublocade, Subutex), and methadone. Our MAT program offers both naltrexone and buprenorphine. Methadone is only available through a certified Opioid Treatment Program (OTP). If you decide on this option, we can help connect you with a local OTP.

For alcohol use disorder, the most common medications used include naltrexone (Vivitrol), acamprosate (Campral), and disulfiram (Antabuse).

Currently, there are no FDA-approved medications to treat other substance use disorders. However, there are several medications that have shown benefit for the treatment of other substance use disorders that can be recommended when you meet with our healthcare team.

How do I get started?

Contact Ryan Deglow, CADTP program supervisor, at 262-945-0995 for more information on how to enroll.